Despite severe pressure arising from the coronavirus pandemic, global health regulations could be a beneficiary in the new normal.
Life Science & Health
HR Can Lead the Fight Against COVID-19
We don’t know where we are on the COVID-19 curve of confusion and destruction, but how we look back on Spring 2020 depends heavily on how global business responds to the challenge. Government actions are key, but government actions are also by default slow. An important characteristic of the new pandemic is the astonishing speed […]
China Eyes Global Leadership in Rare Disease
In the US, a rare disease is defined as affecting 75 in every 100,000 people. In China, there is not yet a specific definition, but it is under study.
China Tip-Toes Towards Mutual Health Insurance
Financing healthcare around private insurance has been tried but not been successful. The Chengdu pilot would be the first real mutual insurance in China.
China Steps Up Control of Pharma Market
2019 is now really starting in China, with the beginning of the Year of the Pig. Everybody in the China pharma market is focusing on how the new central purchasing pilot will be deployed in the coming months. At first glance it looks familiar, with convergence with known international practices: strengthening of bidding rules, phasing […]
Healthcare in China Addresses Innovation in 2019
Healthcare in China will benefit from Important progress made in 2018 in terms of the registration and approval policy for innovative drugs.
Cornerstone Ramps up Pharma Practice in India
The Life Sciences and Healthcare practice of Cornerstone International Group is gearing up for increased activity in India. Within only a few months of its formation, the team in India has added three senior level executive search resources effective January 1, 2017. India’s pharmaceutical market is the world’s third largest in volume and the largest […]
Pharmaceutical Industry in Mexico: 2016 perspectives
(Or how to be successful in times of uncertainty and constant changes) 2016 will be a year of global as well as local changes in the pharmaceutical industry. Mexico will have a marginal GDP growth and limited government spending in the sector. Industry leaders reflect on their experience and share with us the most relevant […]
China’s Next $100B Market
China today is gearing up for an explosion in the development of private healthcare that is expected to exceed US $100 billion by 2030.
Taiwan Healthcare Leaders Seek Growth In 2016
Taipei, TW, October 28, 2015 — Healthcare CEOs in Taiwan expect to benefit from reforms and growth of healthcare IT in 2016, according to a recent forum organized by Cornerstone International Group here. The meeting of key healthcare leaders launched a new Life Science practice group for Cornerstone International Group in Asia. The organization is […]
LIFE SCIENCE PRACTICE GROUP LAUNCHES IN CHINA
Shanghai, CH, October 20, 2015 – Cornerstone International Group has established a new Health and Life Science Practice Group serving its seven member locations in China and Taiwan. The team leader is Dominic Yim, a seasoned executive with 20 plus years as corporate executive in the medical device industry, the last five years in executive […]